PAPER Yun HM, Kim HS, Park KR, Shin JM, Kang AR, il Lee K, Song S, Kim YB, Han SB, Chung HM, Hong JT
SEARCH RESULTS
329960 RESULTS
PAPER Li B, Yu D, Xu Z
Activated protein C inhibits amyloid β production via promoting expression of ADAM-10.
Brain Res. 2014 Jan 30;1545:35-44. Epub 2013 Dec 12 PubMed: 24333930PAPER Macias MP, Gonzales AM, Siniard AL, Walker AW, Corneveaux JJ, Huentelman MJ, Sabbagh MN, Decourt B
A cellular model of amyloid precursor protein processing and amyloid-β peptide production.
J Neurosci Methods. 2014 Feb 15;223:114-22. Epub 2013 Dec 12 PubMed: 24333289PAPER Joshi YB, Giannopoulos PF, Chu J, Praticò D
Modulation of lipopolysaccharide-induced memory insult, γ-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenase.
Neurobiol Aging. 2014 May;35(5):1024-31. Epub 2013 Nov 22 PubMed: 24332986PAPER Cheng X, He P, Lee T, Yao H, Li R, Shen Y
High activities of BACE1 in brains with mild cognitive impairment.
Am J Pathol. 2014 Jan;184(1):141-7. PubMed: 24332014PAPER Olsson B, Legros L, Guilhot F, Strömberg K, Smith J, Livesey FJ, Wilson DH, Zetterberg H, Blennow K
Imatinib treatment and Aβ42 in humans.
Alzheimers Dement. 2013 Dec 10; PubMed: 24331439PAPER Baptista FI, Henriques AG, Silva AM, Wiltfang J, da Cruz e Silva OA
Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.
ACS Chem Neurosci. 2014 Feb 19;5(2):83-92. Epub 2014 Jan 3 PubMed: 24328060PAPER Lopes P, Dyrnesli H, Lorenzen N, Otzen D, Ferapontova EE
Electrochemical analysis of the fibrillation of Parkinson's disease α-synuclein.
Analyst. 2014 Feb 21;139(4):749-56. PubMed: 24343298PAPER Fellner L, Wenning GK, Stefanova N
Models of Multiple System Atrophy.
Curr Top Behav Neurosci. 2013 Dec 14; PubMed: 24338664PAPER Dikiy I, Eliezer D
N-terminal acetylation stabilizes N-terminal helicity in lipid- and micelle-bound α-synuclein and increases its affinity for physiological membranes.
J Biol Chem. 2014 Feb 7;289(6):3652-65. Epub 2013 Dec 12 PubMed: 24338013PAPER Tsunemi T, Krainc D
Zn²⁺ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation.
Hum Mol Genet. 2014 Jun 1;23(11):2791-801. Epub 2013 Dec 13 PubMed: 24334770PAPER Zetterberg H, Petzold M, Magdalinou N
Cerebrospinal fluid α-synuclein levels in Parkinson's disease--changed or unchanged?
Eur J Neurol. 2014 Mar;21(3):365-7. Epub 2013 Dec 16 PubMed: 24330157PAPER Ivanova MI, Sievers SA, Guenther EL, Johnson LM, Winkler DD, Galaleldeen A, Sawaya MR, Hart PJ, Eisenberg DS
Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS.
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1) Epub 2013 Dec 16 PubMed: 24344300PAPER Tagashira H, Shioda N, Fukunaga K
WITHDRAWN: A mutation in the chaperone σ1-receptor impairs mitochondrial ATP production in amyotrophic lateral sclerosis.
J Biol Chem. 2014 Jan 7; PubMed: 24338012PAPER Chiò A, Hammond ER, Mora G, Bonito V, Filippini G
Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis.
J Neurol Neurosurg Psychiatry. 2013 Dec 13; PubMed: 24336810Current Filters
No filters selected